Disease modifying treatments and symptomatic drugs for cognitive impairment in multiple sclerosis: where do we stand?
نویسندگان
چکیده
Cognitive dysfunction is frequent in multiple sclerosis patients and has important and negative consequences for daily activities and quality of life of subjects. Disease modifying treatments for multiple sclerosis reduce the incidence of relapses and may prevent disease progression, but the influence on cognitive impairment is unclear, due to several limitations of the available studies. Moreover, symptomatic drugs for the improvement of already established cognitive deficits have been tested in small pilot studies, providing conflicting or mainly negative results. Currently, specific pharmacological therapies for the management of cognitive deficits in MS have not yet been developed. We will provide an updated overview of available evidence of pharmacological approaches for ameliorating cognitive deficits, based either on disease modifying treatments or symptomatic drugs.
منابع مشابه
Non-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis
Background: Multiple Sclerosis (MS) is a debilitating disease of the central nervous system. Usually, long-term MS medications are injected intramuscularly or subcutaneously, making them intolerable for many MS patients. Objectives: In the present study, the rate and the causes of non-adherence to MS disease-modifying drugs (DMDs) were assessed in patients with MS. Materials and Methods: Two ...
متن کاملInvestigating the Relationship Between Individual and Clinical Characteristics and Executive Dysfunction of Multiple Sclerosis Individuals
Objective Multiple Sclerosis (MS) is the most prevalent neurological progression that often affects young adults. Cognitive impairment is a frequent symptom of the disease. One cognitive domain is an executive function. Executive function is important in individuals’ cognitive skills, adaptive behaviors, and life satisfaction. Thus, accurately recognizing and investigating the factors affectin...
متن کاملThe Effectiveness of Mindfulness-Based Cognitive Therapy in Reducing Psychological Symptoms, Meta-Worry and Thought Fusion of Multiple Sclerosis Patients
Purpose: Multiple sclerosis is a progressive neurological disease and a cause of many disabilities in individuals. Set of symptoms and the chronic nature of this disease, together impair the mental state of the person and cause awidervariety of psychological symptoms worsening the disease. Therefor, this study aimed to evaluate the effectiveness of cognitive therapy based on mindfulness psy...
متن کاملAccess and barriers to MS care in Latin America
Multiple sclerosis (MS), an epidemiologically emergent disorder in Latin America (LATAM), poses substantial socioeconomic challenges to a region where most countries remain as economies in development. MS is not health priority despite its economic and communitarian impact with a relatively low prevalence. MS treatments in LATAM have evolved from earlier long-term oral steroids and immunosuppre...
متن کاملManagement of Motor Symptoms in Multiple Sclerosis
Although there has been a significant development, in recent years, regarding disease modifying treatments (DMT) in multiple sclerosis (MS), there is a continuous need to manage the wide range of symptoms associated with MS. Although surveys vary in their results, mobility is a major concern in MS patients. However, limited evidence exists for symptomatic drug treatment and so it is important t...
متن کامل